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ABSTRACT
Stockouts have previously been reported to interrupt immunization services in low-andmiddle income countries. However, there has been little research to understand the direct impact
of stockouts on the number of children immunized and no research to understand the impact on
under-five mortality. Using panel data from Tanzania’s Vaccine Information Management
System training program, a regression model with fixed and random effects is used to analyze
the effect of stockouts on the number of children immunized. The Lives Saved Tool® is used to
estimate the effect of stockouts on under-five mortality. The results suggest that stockouts have a
statistically significant impact on the number of children immunized for most vaccines in the
current month and for several months after the stockout. No impact was found on under-five
mortality. However, due to limitations in this analysis, this relationship should be further
explored.

EXECUTIVE SUMMARY
Stakeholders of immunization supply chains and programs in low-and-middle income
countries have a goal to increase immunization coverage and improve patient health outcomes
through their services. This includes ensuring vaccine availability through maintaining adequate
stock levels. Stockouts are a typical indicator collected by immunization supply chain managers
to measure vaccine availability. A stockout is usually defined as an entity reporting zero stock of
a vaccine or supply in stock. However, little research has been done to understand the effect
stockouts have on the number of children immunized. Additionally, no research has been done to
understand the effect stockouts have on patient health outcomes, such as mortality.
The first focus of this paper is to measure the number of children immunized over time as
a result of increased stockouts reported by health facilities in mainland Tanzania. This is done by
2

using a panel data regression model of data from Tanzania’s Vaccine Information Management
System training program. The second focus of this paper is to estimate the impact on under-five
mortality as a result of increased stockouts reported by health facilities. This estimate is done
using the Lives Saved Tool®.
The findings of this analysis indicated that stockouts have an influence on the number of
children immunized not only in the current month of the stockout, but also for several months
after. The findings also indicated that stockouts did not influence under-five mortality. However,
this is probably due to Tanzania’s high immunization rates. With high immunization rates it
would be difficult to detect a difference in under-five mortality on the national level. In
conclusion, vaccine availability influences the number of children immunized in mainland
Tanzania, but further research is needed to understand the influence on under-five mortality
because of limitations in this analysis.

INTRODUCTION
Evidence has shown that immunizations are one of the most cost-effective global public
health interventions, saving an estimated two to three million lives every year.1 Since the
introduction of the Expanded Programme on Immunization by the World Health Organization in
1974, global immunization coverage to prevent tuberculosis, diphtheria, tetanus, pertussis,
poliomyelitis, and measles has grown from less than 5% to 86%.2 These programs have
continued to expand, and the World Health Organization now recommends vaccines against
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eleven diseases for infants; tuberculosis, hepatitis B, polio, diphtheria, tetanus, pertussis,
Haemophilus influenzae type b, pneumococcus, rotavirus, measles, and rubella.3
Despite this expansion, Gavi’s 2018 Annual Report indicates that coverage for certain
immunizations in low- and middle-income countries (LMICs) has slightly declined or plateaued
in recent years. While third-dose pentavalent vaccine coverage which protects against diphtheria,
tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b increased from 80% to 82%
between 2015 and 2017, there was a decline to 81% in 2018.4 Four countries that once
transitioned to the high coverage threshold of >80% fell below this mark. Additionally, the firstdose measles vaccine has plateaued at 81% and second-dose coverage is at just 54% in Gavieligible countries.5 Gavi, The Vaccine Alliance is an alliance of global partners aimed at
increasing immunization coverage in LMICs. Countries are eligible for Gavi support based on
their gross national income.
Demand influencing factors such as wealth, educational status of the mother, and
geographical distance to the health center have been reported to impact immunization coverage
in LMICs.6 Factors influencing supply of vaccines, such as cost, have also been shown to impact
immunization coverage as well, especially in middle-income countries never eligible for Gavi
support. Adoption of new vaccines in these countries is slower due to higher procurement costs.
Middle-income countries never eligible for Gavi support were responsible for 17% of the

Feikin, Daniel R., Brendan Flannery, Mary J. Hamel, Meghan Stack, and Peter M. Hansen. “Vaccines for Children
in Low- and Middle-Income Countries.” In Reproductive, Maternal, Newborn, and Child Health: Disease Control
Priorities, Third Edition (Volume 2), edited by Robert E. Black, Ramanan Laxminarayan, Marleen Temmerman, and
Neff Walker. Washington (DC): The International Bank for Reconstruction and Development / The World Bank,
2016.
4
2018 Annual Progress Report, Gavi, The Vaccine Alliance, pp 13.
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world’s under-immunized children in 2017.7 Cost does not seem to be an influencing factor in
Gavi-supported LMICs because of funding support from Gavi and similar stakeholders.
Stock related issues within immunization supply chains have also influenced the supply
of vaccines as well as immunization services. In the 2018 Assessment Report of the Global
Vaccine Action Plan, 70 countries experienced stockouts in 2017 and 69 experienced subnational stockouts. A stockout was defined as a facility reporting zero vaccines in-stock. Subnational stockouts were responsible for the interruption of immunization services in 78% of the
cases. Among LMICs, causes of stockouts identified in the report included stock management
issues, vaccine quality issues, procurement delays, global vaccine shortages, funding delays, and
other non-specified issues.8
With supply chain logistic issues resulting in stockouts and interruption of immunization
services, it is important to understand the impact vaccine availability has on the number of
children immunized and under-five mortality. There have been several studies that evaluate the
impact of supply chain interventions and redesign on improving vaccine availability and
immunization coverage. However, most of these studies do not directly link improved vaccine
availability to increased immunization coverage, nor do they consider the impact on population
health such as under-five mortality. Vaccines are a unique life-saving intervention, in that they
provide protection beyond the person immunized through preventing the spread of disease within
a population.9 Analyzing how vaccine availability impacts the number of children immunized
and under-five mortality will provide stakeholders with a better understanding of how their

Silverman, Rachel & Glassman, Amanda. “New Gavi Modalities for a Changing World.” Global Immunization
and Gavi: Five Priorities for the Next Five Years (2019). pp 20.
8
2018 Assessment report of the Global Vaccine Action Plan. WHO. pp 6
9
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Academy of Sciences 114, no. 16 (April 18, 2017): 4031.
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services affect the populations they serve. This may have been difficult to analyze in the past
because logistic management information systems and health information systems are often
separate. Thanks to a novel electronic logistic management information system implemented in
the United Republic of Tanzania and the Lives Saved Tool®, this type of analysis can now be
performed.
The United Republic of Tanzania is an appropriate country to use for this analysis
because its immunization trends reflect those outlined in Gavi’s 2018 Annual Report. According
to Tanzania’s 2010-2015 multi-year plan submitted to Gavi, antigen coverage was reported to be
98.4% for BCG (Bacille Calmette-Guerin vaccine), 94.7% for DTP3 (third dose diphtheria,
tetanus, pertussis, Haemophilus influenzae B, and hepatitis B vaccine), and 84.4% for measles.
While immunization coverage is high, there is significant regional variation. Additionally, the
proportion of districts with DTP3 coverage less than 80% increased from 9.4% in 2004 to 21%
in 2010.10 Tanzania has 26 regions and 131 districts.
The United Republic of Tanzania is made up of mainland Tanzania and Zanzibar.
Mainland Tanzania and Zanzibar have separate governing bodies for health with the Ministry of
Health, Community, Development, Gender, Elderly, and Children overseeing services of
Tanzania’s mainland and the Ministry of Health overseeing Zanzibar.11 Immunization services
are provided throughout the country and are free in both public and private health facilities. The
distribution of vaccines and supervision of immunization services is managed at the district
level.12 Currently, the World Health Organization recommends vaccination against 14 different

10

The United Republic of Tanzania: Ministry of Health and Social Welfare-Tanzania Mainland. Expanded
Programme on Immunzation 2010 - 2015 Comprehensive Multi Year Plan (2011). pp 5.
11
The United Republic of Tanzania: Ministry of Health and Social Welfare-Tanzania Mainland. Expanded
Programme on Immunzation 2010 - 2015 Comprehensive Multi Year Plan (2011). pp 1.
12
The United Republic of Tanzania: Ministry of Health and Social Welfare-Tanzania Mainland. Expanded
Programme on Immunzation 2010 - 2015 Comprehensive Multi Year Plan (2011). pp 2.

6

antigens in Tanzania.13 Immunizations that target children under five years can be seen in Table
1 below.
Table 1: United Republic of Tanzania Immunization Schedule for Children <5 years
Antigen
Description
Schedule
BCG
Bacille Calmette-Guerin
Birth
vaccine
DTP-Hib-HepB
Diphtheria and Tetanus and
6, 10, 14 weeks
Pertussis and Haemophilus
influenzae B and Hepatitis B
vaccine
IPV
Inactivated polio vaccine
14 weeks
MR
Measles and rubella vaccine
9, 18 months
OPV
Oral polio vaccine
Birth; 6, 10, 14 weeks
PCV-13
Pneumococcal conjugate
6, 10, 14 weeks
vaccine
Rotavirus
Rotavirus vaccine
6, 14 weeks

LITERATURE REVIEW
As mentioned previously, several published studies demonstrate interventions on
immunization supply chains increase the availability of vaccines and reduce the number of
stockouts in LMICs. Some of the research indicates an increase in immunization coverage during
the same time period, but this was not directly linked to increased vaccine availability. Underfive mortality is an important population health outcome collected by stakeholders and is
important to consider since immunization schedules target this vulnerable age group. However,
none of the studies were able to evaluate the impact of vaccine availability on under-five
mortality.
One tool that has been proposed for vaccine management is an electronic logistic
management information system (eLMIS). A study evaluating the effectiveness of an eLMIS for

13
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vaccine management in India found the number of zero-stock events dramatically reduced after
adoption of the system.14 Zero-stock events were defined as the number of transactions, per
month, in which the closing balance of materials was zero. The zero-stock event was classified
as a stockout if the amount remained zero at the start of the following session day. While the
overall number of zero-stock events reduced, suggesting an improvement in stock management,
the proportion of stockouts did not change.
Redesigning delivery systems has also influenced stockouts and immunization coverage.
Sarley, et al. (2017), evaluated complete immunization supply chain redesign in Nigeria, which
included improving data visibility and cold chain equipment, transforming the delivery system to
an informed push model, and strengthening organizational leadership and performance culture.15
The authors found a dramatic decrease in the number of health facilities reporting stockouts,
from 43% to 0%, in a pilot district after the push delivery system was implemented. The push
delivery system consisted of direct to facility customized delivery schedules. Immunization
coverage in these facilities increased from 57% to 88% as well during the same time period.
A second study analyzed supply chain redesign on the state level in Kano, Nigeria. Aina,
et al. (2017), also evaluated the effect of the push delivery system and found a decrease in
stockout rates, from 41% to 10%, after the first delivery cycle.16 Immunization coverage for most
vaccines also improved during the review period. DTP3, OPV (oral polio vaccine), BCG, and
yellow fever all showed significant upward trends. The measles vaccines also displayed an

Gilbert, Sarah Skye, Neeraj Thakare, Arun Ramanujapuram, and Anup Akkihal. “Assessing Stability and
Performance of a Digitally Enabled Supply Chain: Retrospective of a Pilot in Uttar Pradesh, India.” Vaccine,
Building Next Generation Immunization Supply Chains, 35, no. 17 (April 19, 2017): 2203–8.
15
Sarley, David, Mustafa Mahmud, Jide Idris, Modele Osunkiyesi, Onome Dibosa-Osadolor, Peter Okebukola, and
Owens Wiwa. “Transforming Vaccines Supply Chains in Nigeria.” Vaccine 35, no. 17 (April 2017): 2167–74.
16
Aina, Muyi, Uchenna Igbokwe, Leke Jegede, Rabiu Fagge, Adam Thompson, and Nasir Mahmoud. “Preliminary
Results from Direct-to-Facility Vaccine Deliveries in Kano, Nigeria.” Vaccine, Building Next Generation
Immunization Supply Chains, 35, no. 17 (April 19, 2017): 2175–82.
14
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upward trend, but this was not statistically significant. The hepatitis B vaccine displayed a
statistically significant downward trend.
Similarly, a report of immunization supply chain redesign in Mozambique analyzed the
impact of their strategies on vaccine management. These strategies included using a modeling
system, improving data visibility and cold chain equipment, partnering with the private sector for
delivery systems, and leadership engagement.17 The authors of this report found a decrease in the
number of health facilities reporting stockouts after supply chain redesign. Stockouts decreased
from an average of 36% in 2010 to 5% in 2015. This report defined stockouts as “the percentage
of visited health centers during a distribution period that reported a stockout of a specific antigen
at the time of delivery (and before restocking by distribution team).”
To this author’s knowledge there is only one published study directly evaluating the
impact of vaccine availability on immunization coverage and none that evaluate the impact of
vaccine availability on under-five mortality. A recently published study using data from Nigeria
analyzed the effect of vaccine availability on immunization coverage as well as supply and
demand factors that affect this relationship.18 The authors found vaccine stockouts significantly
decreased the number of children immunized with effects lasting several months after a stockout
occurred. Some of this demand was recovered as a result of children “catching-up” with their
immunization regimens, however the author’s concluded that about half of the demand was
permanently lost. The authors of this study suggested the lasting loss in demand was a result of
“learning effects” from vaccine stockouts. These learning effects included loss of trust in the
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healthcare system by the child’s mother which would prevent the mother from returning for
future immunizations, as well as parents informing neighbors of a stocked-out facility which
would discourage others from taking their children to the facility for immunizations. This study
is limited in its external validity, however, as the structure of immunization supply chains varies
among LMICs.
Additional studies are needed to confirm the impact of vaccine availability on
immunization coverage. A majority of previously published studies do not directly analyze the
effect of vaccine availability on the number of children immunized. It is important for
stakeholders to know if stockouts are indeed influencing immunization coverage over time. This
could indicate children are being lost to follow-up because of trust in the health care system
which would put children at risk for contracting and spreading deadly diseases. Further research
may be needed to understand when, and if, children eventually catch up with their immunization
regimens. Additionally, this could indicate the need for campaign outreach after significant
regional or national stockouts. Lastly, studies involving vaccine availability have not been able
to measure population health outcomes such as under-five mortality. Understanding the impact
vaccine availability has on under-five mortality will provide stakeholders additional insight into
how their immunization supply chain services affect the populations they serve.

OBJECTIVE AND HYPOTHESIS
The objective of this capstone is to answer the following two research questions: 1) What
is the effect of vaccine availability on the number of children immunized in Tanzania? and 2)
What is the effect of vaccine availability on under-five mortality in Tanzania? In this analysis,
the outcome measures of interest are the number of children immunized and under-five mortality
estimated as a result of stockout events. Stockout events serve as a measure of vaccine
10

availability. A stockout is defined as a health facility reporting zero stock of a vaccine or supply
in each month. Given previous findings on stockouts and immunization coverage, I hypothesize
that an increase in the number of stockout events will result in a decrease in the number of
children immunized and that this trend will last for several months following the stockout event.
Additionally, I hypothesize that under-five mortality will increase as a result of the increase in
number of stockout events.

RESEARCH DESIGN
The first aim of this study is to analyze the effect of stockouts on the number of children
immunized in Tanzania using a regression of panel data with fixed and random effects.
Reporting standards for Tanzania’s Vaccine Information Management System (VIMS) was
rolled out in phases over time to different areas of the country. Data from VIMS training
program, the data source for this analysis, reflects this phenomenon. It could be expected that as
more health facilities adopt VIMS over time, the absolute number of children immunized would
increase as health facility workers receive additional training and partake in better data
collection. A concern of using this model is omitted variable bias. Using the Hausman test for
each regression model, there is no evidence that region-specific omitted variables correlate with
observed explanatory variables.
The second aim of this study is to estimate the effect of vaccine availability on under-five
mortality in Tanzania using the Lives Saved Tool®. This tool provides an estimate on mortality
rates from the scale-up of certain health interventions, such as the scale-up of immunizations.
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COUNTRY SELECTION AND DATA SOURCES
The United Republic of Tanzania was chosen for this analysis because of reasons stated
in the introduction of this paper and because of recent implementation of VIMS. VIMS is a semiautonomous module of Tanzania’s electronic logistic management information system and was
implemented in mainland Tanzania under the leadership of the Ministry of Health, Community,
Development, Gender, Elderly, and Children and in partnership with US Agency for
International Development, the Bill and Melinda Gates Foundation, and Gavi with the Clinton
Access Initiative, John Snow, Inc., PATH, and VillageReach. VIMS combines data from three
different systems that were once operating in silos: the District Vaccine Data Management Tool,
the Stock Management Tool, and the Cold Chain Equipment Inventory Tool. Essentially, VIMS
allows stock to be tracked as it moves along the supply chain all the way until stock is used.
Health facilities are expected to count stock on hand at the end of each month and enter this
information into VIMS along with other key performance indicators. This includes submitting
information on the number of children vaccinated according to records in the electronic
immunization registry. This information can then immediately be transmitted to district level
supply chain managers. VIMS became the national reporting standard for vaccine stock
management in January 2019.
It had been intended to use data from January 2019 through December 2019 for this
analysis, however the author was unable to access the actual data collected in VIMS. Instead the
data source for this analysis is the VIMS training program. The VIMS training program was
designed to train health facility workers and program managers on how to input information into
the system and generate reports. The training program does not contain real data. While data
from the training program is not real data collected, it mirrors actual trends observed across
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mainland Tanzania and will serve the purpose of this paper. Data obtained from the training
program includes the number of health facilities that reported a stockout and the number of
children immunized for the following four vaccines per region per month: Measles and rubella
(MR), rotavirus (RV), pneumonococcal conjugate (PCV-13), and diphtheria, tetanus, pertussis,
Haemophilus influenzae type b and hepatitis B (DTP-Hib-HepB). Additional data obtained from
the training site includes total target population as well as the number of health facilities
expected to report into VIMS each month. Data is also obtained from Tanzania’s 2015-2016
Demographic and Health Survey and Malaria Indicator Survey. This includes information on
wealth and education status of females.19 Data is aggregated at the regional level for all 26
regions in mainland Tanzania. The research protocol was approved by the University of
Kentucky Institutional Review Board.

POPULATION AND OUTCOME MEASURES
The target population is children five-years and younger living in mainland Tanzania
between the time period January 1, 2018 through December 31, 2018. The outcome measures of
interest are the number of children immunized for each of the following four vaccines: MR, RV,
PCV-13, and DTP-Hib-HepB. This is measured as the absolute number of children immunized
for each vaccine.

19

Ministry of Health, Community Development, Gender, Elderly and Children (MoHCDGEC) [Tanzania
Mainland], Ministry of Health (MoH) [Zanzibar], National Bureau of Statistics (NBS), Office of the Chief
Government Statistician (OCGS), and ICF. “Tanzania Demographic and Health Survey and Malaria Indicator
Survey (TDHS-MIS) 2015-16.” Dar es Salaam, Tanzania, and Rockville, Maryland, USA: MoHCDGEC, MoH,
NBS, OCGS, and ICF. (2016). pp 35 & 42.
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EXPLANATORY VARIABLES
The explanatory variable of direct interest is vaccine availability. Vaccine availability is
defined as the number of health facilities that reported a stockout per region per month. Other
variables that have been shown to influence the number of children immunized in LMICs include
wealth, education status of the mother, and size of target population. Therefore, these variables
are included in the model. Wealth is defined as the Gini coefficient reported for each region,
education status of the mother as the median years of schooling completed by females in each
region, and target population as the number of children under five-years in each region. The
number of health facilities expected to report into VIMS per region per month is also included as
an explanatory variable. A table of explanatory variables along with their definition and source
can be seen below in Table 2.

14

Table 2: Description of Explanatory Variables
Variable Name
Definition
stockoutMR
The number of health
facilities reporting zero stock
of MR vaccine each month
stockoutRota
The number of health
facilities reporting zero stock
of rotavirus vaccine each
month
stockoutPCV13
The number of health
facilities reporting zero stock
of PCV-13 vaccine each
month
stockoutDTP
The number of health
facilities reporting zero stock
of DTP-Hib-HepB vaccine
each month
healthfac
The number of health
facilities expected to submit
reports into VIMS each
month
targetpop
The number of children under
five years in each region
motheredu
Median years of schooling
completed by females in each
region
ginicof
Gini coefficient in each
region

Source
VIMS training program

VIMS training program

VIMS training program

VIMS training program

VIMS training program

VIMS training program
2015-2016 DHS-MIS

2015-2016-MIS

STATISTICAL ANALYSIS
The equation for the panel data regression model is shown below:
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝐶ℎ𝑖𝑙𝑑𝑟𝑒𝑛 𝐼𝑚𝑚𝑢𝑛𝑖𝑧𝑒𝑑𝑖𝑡
= 𝛽0 + 𝛽1 (𝑠𝑡𝑜𝑐𝑘𝑜𝑢𝑡)𝑖𝑡 + 𝛽2 (ℎ𝑒𝑎𝑙𝑡ℎ𝑓𝑎𝑐)𝑖𝑡 + 𝛽3 (𝑡𝑎𝑟𝑔𝑒𝑡𝑝𝑜𝑝)𝑖𝑡
+ 𝛽4 (𝑚𝑜𝑡ℎ𝑒𝑟𝑒𝑑𝑢)𝑖𝑡 + 𝛽5 (𝑔𝑖𝑛𝑖𝑐𝑜𝑓)𝑖𝑡 + 𝛼𝑖 + 𝑢𝑖𝑡
The above model will be used to run separate regressions for each of the four vaccines
included in this analysis and will be lagged to prevent analysis of a definitional relationship
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between the amount of vaccines available and the rate of immunization. All statistical analyses
are performed using Stata v16.1.

LIVES SAVED TOOL
Using the outputs from the above panel data regression model for each vaccine and the
Lives Saved Tool®, the effect of vaccine availability on under-five mortality can be estimated.
The Lives Saved Tool®, developed by Johns Hopkins Bloomberg School of Public Health and
funded by the Bill and Melinda Gates Foundation, is a mathematical linear model for LMICs that
estimates population health outcomes from the scale-up of certain health interventions.20 The
methodology of the tool is described elsewhere.21 The tool is regularly updated with evidence
from the latest scientific literature and demographic household surveys and includes data for all
four vaccines included in this analysis. A complete look of data included in the model can be
visualized at listvisualizer.org.
A baseline projection for the year 2018 will first be computed to serve as the
counterfactual for the second part of this analysis. A second projection will then be computed
using the outputs from the four regression models with a one-month lag. The impact on underfive mortality from vaccine availability can then be estimated by comparing this second
projection to the counterfactual.

“About — The Lives Saved Tool.”
Walker, Neff, Yvonne Tam, and Ingrid K Friberg. “Overview of the Lives Saved Tool (LiST).” BMC Public
Health 13, no. Suppl 3 (September 17, 2013)
20
21
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RESULTS
Not surprising, the analysis found that stockouts have a statistically significant influence
on the number of children immunized for most vaccines in the current month of the stockout.
However, results suggest that this influence lasts several months following the month of
stockout. This finding was significant for all vaccines. The second part of this analysis did not
find that stockouts have an influence on under-five mortality.

SUMMARY STATISTICS
Summary statistics for each of the 26 regions in mainland Tanzania over the year 2018
can be seen in Table 3 below. There was a total of 228 observations for regions reporting the
number of vaccines given and the number of stockouts in each month. Missing observations
reflect when VIMS was not operational in certain regions at a point in time; therefore, there was
no data to observe. Missing observations were dropped from the analysis. The number of
children immunized varied greatly between vaccine type and region, with the minimum number
of children immunized being equal to 0 (MR vaccine) and the maximum number of children
immunized equal to 953,056 (Rotavirus vaccine). Target population, education of the mother,
and Gini coefficient also varied for each region. The mean target population was equal to
346,620 children, mean education of the mother equal to 4.172 years, and mean Gini coefficient
equal to 0.4696. The number of health facilities reporting a stockout of a vaccine in each month
varied depending on vaccine type. On average the number of health facilities reporting a
stockout in each region per month was greatest for the DTP-Hib-HepB vaccine (21.8). This was
followed by the MR vaccine (19.2), PCV-13 vaccine (15.7), and rotavirus vaccine (13.5).
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Table 3: Summary Statistics
Variable
DTP Vaccine
MR Vaccine
PCV-13 Vaccine
Rotavirus Vaccine
Target Population
Mother’s Education (years)
Gini Coefficient
No. of Health Facilities
No. of Health Facilities
Reporting DTP Vaccine
Stockout
No. of Health Facilities
Reporting MR Vaccine
Stockout
No. of Health Facilities
Reporting PCV-13 Vaccine
Stockout
No. of Health Facilities
Reporting Rotavirus Vaccine
Stockout

Obs
228
228
228
228
312
300
300
312
228

Mean
94,337
56,304
93,679.36
67,242.54
346,620
4.172
0.4696
166
21.8

Std.Dev.
82,474.28
50,183.07
81,861.02
80,973.14
215,121.8
1.493
0.1340
120.27
18.2

Min
118
0
195
126
23,850
1.8
0.08
0
0

Max
426,237
237,364
414,205
953,056
958,784
6.6
0.7
346
97

228

19.2

16.3

0

89

228

15.7

14.5

0

72

228

13.5

13.0

0

68

EFFECT OF VACCINE STOCKOUTS ON NUMBER OF CHILDREN IMMUNIZED
The number of health facilities reporting a stockout had a statistically significant impact
on the number of children immunized for most vaccines in the current month. The exception for
this was the impact of stockouts on the number of children immunized with the DTP-Hib-HepB
vaccine (p=0.063). When analyzing the effect of the number of health facilities reporting a
stockout in the previous month on the number of children immunized, the effect was statistically
significant for all vaccines. This effect was statistically significant for a one-, two-, and threemonth lag for all vaccines. These results can be seen below in Table 4. The number in
parentheses is the standard error for each coefficient. The asterisk indicates the level of statistical
significance.
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Table 4: Effect of Stockouts on Number of Children Immunized
DTP Vaccine
MR Vaccine
PCV-13
Vaccine
Current Month
-755.6 (406.1)
-969.7* (267.2)
-1,967.9*
(490.4)
One-Month Lag -943.6* (406.3)
-899.0* (262.3)
-1,949.9*
(484.8)
Two-Month Lag -1,053.2*
-821.2* (259.4)
-1,765.1*
(395.1)
(476.8)
Three-Month
-996.2* (384.7)
-667.6* (254.7)
-1,654.4*
Lag
(456.5)
*p<0.05

Rotavirus
Vaccine
-1,380.0*
(504.4)
-1,304.4*
(506.2)
-1,432.1*
(533.6)
-1,447.9*
(587.1)

EFFECT OF VACCINE STOCKOUTS ON UNDER-FIVE MORTALITY ESTIMATE
A baseline projection estimated the mortality rate to be 54.0 deaths per 1,000 live births
in the year 2018. After accounting for the number of children who missed immunizations as a
result of the number of health facilities reporting a stockout in the previous month, the projection
estimated the mortality rate to stay constant at 54.0 deaths per 1,000 live births. These results can
be seen below in Table 5.
Table 5: Projection of Under-Five Mortality Estimate in 2018
Projection
Under-Five Mortality Estimate (deaths per
1,000 live births)
Baseline
54.0
Final
54.0

DISCUSSION
The above results suggest that stockouts have an influence on the number of children
immunized each month. The results of this analysis also suggest this impact stays constant for
several months following the reported stockout event. These results support those found in
Gooding, et al. (2019), further confirming the impact that stockouts have on the number of
children immunized. These findings suggest that children may be lost to follow-up after being
denied a vaccination due to a stockout. However, because of the structure of this analysis and
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available data, the model used may not accurately reflect the significance of stockouts on the
number of immunizations given. Gooding, et al. (2019), determined that children “catch-up” on
their immunizations through campaign outreach. The effect of campaign outreach could not be
determined in this analysis based on available data. It is probable that campaign outreach could
influence the number of children immunized, showing an increase in the number of children
immunized over time. This would lessen the impact of stockouts on the number of
immunizations given over time. Also, education of the mother (motheredu) and Gini coefficient
(ginicof) are nearly perfectly collinear with other included variables. Therefore, the influence of
these two variables on the number of children immunized could not be estimated based on
available data. Distance to health facility has also been reported to influence immunization, but
this could not be controlled based on available data. These lack of control variables may
overestimate the influence stockouts have on the number of children immunized.
This analysis found stockouts did not influence under-five mortality in Tanzania. This is
likely a result of Tanzania’s high immunization rates and should not downplay the significance
of vaccines. It is likely that the decrease in immunizations given would have an impact on
increasing under-five morality estimate. However, since the Lives Saved Tool® measures this
estimate at the national level, this result was not large enough to show an impact on mortality. It
is possible an impact on under-five mortality could have been estimated if the first part of this
analysis was done at the national level instead of at the regional level.

LIMITATIONS
This analysis has several limitations that must be mentioned. First, it must be noted that
this is not an analysis of real data, but data used for training from the VIMS training program.
While the data from the training program reflects real trends of immunizations and stockout
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events, it is not real data. Therefore, the results should not be used to guide decisions until an
analysis can be completed with actual data collected in VIMS. Secondly, it is a limitation that
there are missing observations in the data set. It is possible the true impact of stockouts on the
number of children immunized was not measured because not all months for each region could
be accounted for based on when the regions were expected to start using VIMS. This could also
be the case because not all variables that could potentially affect the number of children
immunized could be included, as mentioned above. The variable used as a wealth indicator, the
Gini coefficient, may not be the best indicator of wealth either, but this was the best measure
given available data. Lastly, the results of this analysis are limited in their external validity and
cannot be generalized to other low-and-middle income countries. This is due to differences in
immunization program and supply chain structure among low-and-middle income countries.

CONCLUSION AND RECOMMENDATIONS
In conclusion, the number of health facilities reporting a stockout in the previous
month(s) had a statistically significant impact on the number of children immunized for each of
the following four vaccines: DTP-Hib-HepB, MR, PCV-13, and rotavirus vaccine. The reported
stockouts resulted in a decrease in the number of children immunized. This analysis did not find
the number of health facilities reporting a stockout to have an impact on under-five mortality
estimate. The following recommendations are stated based off this analysis:

Recommendation One:
•

Perform analysis with actual data collected in VIMS. This will allow the true impact of
stockouts on the number of children immunized to be measured and can be used for the
basis of decision making.
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Recommendation Two:
•

Consider collecting the number of children reached through immunization campaigns in
VIMS. As of now, health facilities report the total number of immunizations given per
month into VIMS. It would be beneficial for decision makers to understand how many of
these immunizations are given through campaign outreach in order to decide where to
allocate funds. This would also allow decision makers to understand the influence
campaigns have on the number of children immunized after a reported stockout.

Recommendation Three:
•

Consider performing this analysis at the national level. Performing this analysis at the
regional level does not provide insight into how stockouts effect under-five mortality
estimate with current available tools. The impact on this estimate could be determined by
analyzing stockouts and the number of children immunized at the national level.

Recommendation Four:
•

Encourage timely and accurate reporting at the facility level. Timely and accurate
reporting in VIMS will not only improve vaccine management through ensuring adequate
supply but will also provide insight for decision makers on where improvements can be
made.

Recommendation Five:
•

Continue to support funding of VIMS in Tanzania and implementation of VIMS in other
low-and-middle income countries. VIMS is a novel information system combining
logistic data and health information. This electronic logistic management information
system allows stakeholders to measure the impact of their services and provides insight
for better decision making.
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